Table III.
Composition of medical product and placebo (active ingredients are shown in bold).
| Medical product (Salistat SGL03) | Placebo | ||
|---|---|---|---|
| Vial content | Osmotic water | Osmotic water | |
| Gluco-oligosaccharides; prebiotic | X | ||
| Citric acid | Citric acid | ||
| Potassium sorbate | Potassium sorbate | ||
| Sodium lactate | Sodium lactate | ||
| Vanilla flavor | Vanilla flavor | ||
| Sucralose | Sucralose | ||
| Lemone.o. | X | ||
| Rosemary e.o. | X | ||
| Vial cap | Modified tapioca starch | Modified tapioca starch | |
| Lactoferrin | X | ||
| Live probiotic bacteria (L. salivarius SGL03) | X | ||
| Maltodextrin | Maltodextrin | ||
| Magnesium salts of fatty acids | Magnesium salts of fatty | acids | |
| Silicon dioxide | Silicon dioxide | ||
| cholecalciferol/colecalciferol | X | ||
X – the lack of the ingredient in placebo